Our network analysis identified the gene CHRM3 (the cholinergic muscarinic receptor 3, M3R) which has high betweenness or centrality values, and this receptor has already been studied as an intriguing pharmacological target for glaucoma treatment. This evidence concerns the gene CHRM3 and glaucoma.